000 01520 a2200445 4500
005 20250515191627.0
264 0 _c20100308
008 201003s 0 0 eng d
022 _a1421-9867
024 7 _a10.1159/000235916
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aConnolly, M P
245 0 0 _aQuality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.
_h[electronic resource]
260 _bDigestion
_c2009
300 _a241-6 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdministration, Rectal
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aColitis, Ulcerative
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMesalamine
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aQuality of Life
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aPoole, C D
700 1 _aCurrie, C J
700 1 _aMarteau, P
700 1 _aNielsen, S K
773 0 _tDigestion
_gvol. 80
_gno. 4
_gp. 241-6
856 4 0 _uhttps://doi.org/10.1159/000235916
_zAvailable from publisher's website
999 _c19222297
_d19222297